查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球骨科植入物市场 - 2023-2030年
市场调查报告书
商品编码
1297779

全球骨科植入物市场 - 2023-2030年

Global Orthopedic Implants Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球骨科植入物市场规模在2022年达到447亿美元，预计到2030年将出现有利可图的增长，达到716亿美元。在2023-2030年的预测期内，该市场的年复合增长率为6.2%。

骨科植入物是由各种生物材料开发的，在毒性、细胞毒性和敏化方面进行了生物评估。材料强化技术，如涂层、合金化和抗氧化，被用来提高植入物材料的耐腐蚀性和惰性。

植入物与骨组织的整合目前正受到关注，以提高植入物在治疗骨损伤方面的生物、临床甚至生物力学效益。

市场动态

肌肉骨骼疾病的发病率不断增加

骨折、骨关节炎、骨质疏松症等肌肉骨骼疾病的发病率不断上升，是推动骨科植入物市场份额的主要因素。由于人口老龄化、久坐不动的生活方式和慢性病的增加，肌肉骨骼疾病在全球范围内变得越来越普遍。这些疾病往往需要手术干预和骨科植入物进行关节置换、骨折固定和脊柱稳定。

随着肌肉骨骼疾病的发病率持续上升，人们对骨科植入物的需求不断增加，以恢复活动能力，减轻疼痛，并改善受影响者的生活质量。这种对骨科植入物需求的增加，促进了市场份额的增长。

例如，2023年4月，Globus Medical是一家开发和商业化医疗保健解决方案的医疗器械公司，其使命是改善肌肉骨骼疾病患者的生活质量。Globus致力于医疗器械的创新，并为医院、非住院手术中心和医生提供卓越的服务，以推进病人护理和提高效率。

骨科植入物的高成本

在预测期内，骨科植入物的高成本阻碍了市场的份额。骨科植入物的高成本可能使许多病人无法负担，特别是在医疗资源有限或保险范围不足的地区。这可能导致延迟或推迟手术或考虑其他治疗方案。

在发展中国家，医疗基础设施和资源可能有限，骨科植入物的高成本可能是一个重大障碍。它可能会阻碍先进的植入技术的采用，并限制人们获得高质量的骨科护理。

COVID-19影响分析

COVID-19大流行病对骨科植入物市场产生了重大影响。在大流行期间，人们明显转向远程医疗和远程护理服务，以尽量减少亲临现场，降低病毒传播的风险。然而，骨科手术通常需要亲自评估和操作，限制了远程医疗在这一领域的应用范围。

大流行病造成的经济衰退和COVID-19应对措施的医疗支出增加使医疗预算紧张。医院和医疗机构面临财务挑战，可能导致对骨科植入物和相关程序的投资减少。

俄罗斯-乌克兰冲突分析

俄乌冲突对全球骨科植入物市场产生了重大影响。冲突导致了政治不稳定，造成了不确定性，扰乱了贸易关系。一些国家的政治紧张局势和制裁会影响骨科植入物的进出口，有可能导致供应链的中断和市场的不确定性。

冲突可能限制医疗机构获得骨科植入物技术的最新进展。国际合作、研究和获得尖端植入技术的机会可能会受到阻碍，可能会减缓新植入技术的创新和采用。

目录

第一章：方法和范围

  • 研究方法
  • 报告的研究目标和范围

第二章：定义和概述

第三章：执行摘要

  • 按产品分类的摘要
  • 按材料分类
  • 按终端用户分类
  • 按地区分类

第四章：动态变化

  • 影响因素
    • 驱动因素
      • 肌肉骨骼疾病的发病率越来越高
    • 限制因素
      • 骨科植入物的高成本
    • 机会
    • 影响分析

第五章：行业分析

  • 波特的五力分析
  • 供应链分析
  • 价格分析
  • 监管分析

第六章：COVID-19分析

  • COVID-19的分析
    • COVID-19之前的情况
    • 目前的COVID-19方案
    • 后COVID-19或未来的情况
  • 在COVID-19中的定价动态
  • 需求-供应谱系
  • 大流行期间与市场有关的政府倡议
  • 制造商的战略倡议
  • 结语

第七章：按产品分类

  • 重建性关节置换
  • 脊柱植入物
  • 牙科植入物
  • 骨科生物制品
  • 颅颌面外科
  • 其他

第8章：按材料分类

  • 陶瓷材料
  • 高分子材料
  • 天然材料

第九章：按终端用户分类

  • 医院
  • 骨科诊所
  • 家庭护理
  • 其他

第十章：按地区划分

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第11章 ：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併和收购分析

第十二章 ：公司简介

  • Johnson & Johnson
    • 公司概述
    • 产品组合和描述
    • 财务概况
    • 主要发展情况
  • Zimmer Biomet
  • Stryker Corporation
  • Medtronic Plc
  • Smith and Nephew Plc
  • Wright Medical Group N.V.
  • CONMED Corporation
  • Arthrex Inc.
  • DJO Global
  • Globus Medical

第十三章 ：附录

简介目录
Product Code: MD1970

Market Overview

The Global Orthopaedic Implants market size reached US$ 44.7 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 71.6 billion by 2030. The market is exhibiting at a CAGR of 6.2% during the forecast period 2023-2030.

Orthopedic implants have been developed from various biomaterials biologically evaluated in aspects of toxicity, cytotoxicity, and sensitization. Material enhancement techniques such as coating, alloying, and antioxidation are used to increase the corrosion resistance and inertness of the implant materials.

Integration of the implant into the bone tissue is currently under interest to enhance the biological, clinical, and even biomechanical benefits of the implants in the treatment of bone injuries.

Market Dynamics

Increasing prevalence of musculoskeletal disorders

The increasing prevalence of musculoskeletal disorders such as bone fractures, osteoarthritis, and osteoporosis is the major factor driving the orthopedic implants market share. Musculoskeletal disorders are becoming more prevalent globally due to aging populations, sedentary lifestyles, and increased chronic conditions. These disorders often require surgical intervention and orthopedic implants for joint replacements, fracture fixation, and spinal stabilization.

As the prevalence of musculoskeletal disorders continues to rise, there is a growing demand for orthopedic implants to restore mobility, alleviate pain, and improve the quality of life for affected individuals. This increased demand for orthopedic implants contributes to the growth of the market share.

For instance, in April 2023, Globus Medical, a medical device company that develops and commercializes healthcare solutions and whose mission is to improve the quality of life of patients with musculoskeletal disorders. Globus is committed to medical device innovation and delivering exceptional service to hospitals, ambulatory surgery centers, and physicians to advance patient care and improve efficiency.

High cost of the orthopedic implants

The high cost of the orthopedic implants hamper the market share during the forecast period. The high cost of orthopedic implants can make them unaffordable for many patients, particularly in regions with limited healthcare resources or inadequate insurance coverage. This can result in delayed or deferred surgeries or alternative treatment options being considered.

In developing countries, where healthcare infrastructure and resources may be limited, the high cost of orthopedic implants can be a significant barrier. It can hinder the adoption of advanced implant technologies and restrict access to quality orthopedic care.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the orthopedic implants market. During the pandemic, there was a significant shift towards telemedicine and remote care delivery to minimize in-person visits and reduce the risk of virus transmission. However, orthopedic surgeries typically require in-person evaluations and procedures, limiting the scope of telemedicine in this field.

The economic downturn caused by the pandemic and increased healthcare spending on COVID-19 response strained healthcare budgets. Hospitals and healthcare facilities faced financial challenges, potentially leading to reduced investments in orthopedic implants and related procedures.

Russia-Ukraine Conflict Analysis

The Russia-Ukraine conflict has had a significant impact on the orthopaedic implants market globally. The conflict has resulted in political instability, creating uncertainties and disrupting trade relationships. Political tensions and sanctions imposed by some countries can affect the import and export of orthopedic implants, potentially leading to supply chain disruptions and market uncertainties.

The conflict may limit access to the latest advancements in orthopedic implant technologies for healthcare providers. International collaborations, research, and access to cutting-edge implant technologies may be hindered, potentially slowing innovation and adoption of new implant technologies.

Segment Analysis

The Global Orthopaedic Implants Market is segmented based on product, material, end-user, and region.

Based on the product, reconstructive joint replacements are expected to dominate the market share.

Based on the product, reconstructive joint replacements, such as hip and knee implants, are expected to dominate the market share in the Orthopedic Implants market. Reconstructive joint replacements are surgical procedures that involve replacing a damaged or diseased joint with an artificial implant.

They can alleviate pain, enhance joint function, and improve the overall quality of life for individuals suffering from joint-related issues. The positive patient experiences and long-term benefits have contributed to the dominance of reconstructive joints. For instance, in May 2023, Zimmer Biomet Holdings, a global medical technology leader, announced that it had reached a definitive agreement to acquire OSSIS.

This privately-held medical device company specializes in personalized 3D printed implants and complex hip replacements, including second-time hip replacements and replacements involving bone tumors and trauma. The reconstructive joint replacements segment accounted for the highest market stake, accounting for approximately 32.9% of the orthopedic implants market in 2022.

Geographical Analysis

North America holds the largest market share during the forecast period

North America is estimated to hold around 38.7% of the total market share throughout the forecast period, owing to the development of novel devices and favorable government initiatives. North America is known for its strong research and development capabilities in the medical device industry.

The region has many leading orthopedic implant manufacturers and research institutions continually striving to develop and innovate novel devices. Developing advanced implant technologies, such as 3D printing, bioresorbable, and smart implants, has helped drive market growth in North America.

Government initiatives play a crucial role in shaping the orthopedic implant market. In North America, government bodies and regulatory agencies provide support and create a conducive environment for developing, approving, and adopting orthopedic implants. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) in the United States, ensure safety and efficacy standards while facilitating market entry for innovative devices.

Competitive Landscape

The major global players in the market include: Johnson & Johnson, Zimmer Biomet, Stryker Corporation, Medtronic Plc, Smith and Nephew Plc, Wright Medical Group N.V., CONMED Corporation, Arthrex Inc., DJO Global, and Globus Medical.

Why Purchase the Report?

  • To visualize the Global Orthopedic Implants Market segmentation based on product, material, end-user, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous orthopedic implants market-level data points with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The Global Orthopedic Implants Market Report Would Provide Approximately 54 Tables, 46 Figures And 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Material
  • 3.3. Snippet by End-User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing prevalence of musculoskeletal disorders
    • 4.1.2. Restraints
      • 4.1.2.1. High cost of the orthopedic implants
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Before COVID-19 Scenario
    • 6.1.2. Present COVID-19 Scenario
    • 6.1.3. Post COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Reconstructive joint replacements*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Spinal implants
  • 7.4. Dental implants
  • 7.5. Orthobiologics
  • 7.6. Craniomaxillofacial
  • 7.7. Others

8. By Material

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.1.2. Market Attractiveness Index, By Material
  • 8.2. Ceramics*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Polymeric materials
  • 8.4. Natural materials

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Orthopaedic Clinics
  • 9.4. Homecare
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Johnson & Johnson*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. Zimmer Biomet
  • 12.3. Stryker Corporation
  • 12.4. Medtronic Plc
  • 12.5. Smith and Nephew Plc
  • 12.6. Wright Medical Group N.V.
  • 12.7. CONMED Corporation
  • 12.8. Arthrex Inc.
  • 12.9. DJO Global
  • 12.10. Globus Medical

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us